Putin recalled the results of the Russian-Italian study of vaccines

During a conversation with representatives of Italian business, the President of Russia noted that the process of mutual recognition between the Russian Federation and the European Union has not yet been completed vaccination certificates and vaccines. This, said Vladimir Putin, does not contribute to the activation of business contacts.

In this regard, he recalled the recent joint Russian-Italian comparative study of vaccines, which was carried out by the National Institute of Infectious Diseases (Italy).

According to the results, Putin noted, “the Russian drug Sputnik V demonstrated the highest titer of virus-neutralizing antibodies to the Omicron strain, and thus again proved its high efficiency.”

The President of Russia also said that “because of coronavirus pandemic business contacts have been hampered.” And in general, he added, “the volatile situation in the global economy has not been conducive to the implementation of new projects and initiatives.”

“However, we can state with satisfaction that our countries managed to maintain cooperation on the economic track at a fairly high level,” Vladimir Putin said.

The meeting of the President of Russia with representatives of Italian business was broadcast by the TV channel “Russia 24” and platform “Looking”.

Today it became known that the Ministry of Health of Russia during the pandemic Approved circulation in the territory of the Russian Federation of the drug for the prevention of coronavirus Evusheld company AstraZeneca.

ttn-20

Bir yanıt yazın